Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group is a research paper published in Pediatric Blood & Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: U10 CA180886
NCI NIH HHS
Grant: UM1 CA228823
NCI NIH HHS
Grant: U10 CA180899
St Baldrick's Foundation
Grant: UM1CA097452
NCI NIH HHS
Grant: UG1 CA239771
Cookies for Kid's Cancer
Sebastian Strong Foundation
Summer's Way Foundation
Takeda Pharmaceuticals
National Institutes of Health
Friends of TJ Foundation
NIH HHS
Maddie's Promise Foundation
FWCI
2.02
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals